CYP1A1 and prostate cancer: In our study, ex-smokers who had quit smoking 7 or more days before surgery combined with never-smokers showed higher CYP1A1 methylation levels compared with current smokers, indicating smoking to be a modifiable risk factor for prostate cancer that is dependent on CYP1A1 expression.